BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb price to sales (P/S) ratio

Bristol-Myers Squibb's P/S ratio is 2.59: its market cap of 129.65B USD over revenue of 50.03B USD in the last twelve months.

Today
2.59
Average, 5 years
2.56
Low, 5 years
1.76
High, 5 years
3.70

P/S ratio = market cap ÷ revenue (last 12 months) = 129.65B ÷ 50.03B = 2.59

Each day's market cap over the revenue of the last four quarters reported by that day.

P/S ratio by year and by quarter

Fiscal yearPeriod endingP/S ratioMarket capRevenue
Today2.59129.65B50.03B
FY202531 Dec 20252.28110.09B48.20B
FY202431 Dec 20242.37114.65B48.30B
FY202331 Dec 20232.36106.16B45.01B
FY202231 Dec 20223.32153.25B46.16B
FY202131 Dec 20212.99138.48B46.39B
FY202031 Dec 20203.29140.06B42.52B
FY201931 Dec 20194.19109.44B26.15B
FY201831 Dec 20183.7684.88B22.56B
FY201731 Dec 20174.85100.81B20.78B
FY201631 Dec 20165.0397.65B19.43B
FY201531 Dec 20156.92114.67B16.56B
FY201431 Dec 20146.1697.81B15.88B
FY201331 Dec 20135.3387.38B16.39B
FY201231 Dec 20123.0954.43B17.62B
FY201131 Dec 20112.8259.91B21.24B
FY201031 Dec 20102.3345.36B19.48B
FY200931 Dec 20092.6549.84B18.81B
FY200831 Dec 20082.2345.97B20.60B
FY200731 Dec 20072.7052.24B19.35B
FY200631 Dec 20062.8851.59B17.91B
FY200531 Dec 20052.3444.86B19.21B
FY200431 Dec 20042.5749.75B19.38B
FY200331 Dec 20032.6555.40B20.89B
FY200231 Dec 20022.5546.24B18.12B
FY200131 Dec 20015.0998.94B19.42B
FY200031 Dec 20007.59138.34B18.22B
FY199931 Dec 19996.00121.26B20.22B
FY199831 Dec 19986.92126.59B18.28B
FY199731 Dec 19975.3789.74B16.70B
FY199631 Dec 19963.4652.11B15.07B
FY199531 Dec 19953.0141.37B13.77B
FY199431 Dec 19942.3428.06B11.98B
FY199331 Dec 19932.5128.60B11.41B
FY199231 Dec 19922.9432.84B11.16B
FY199131 Dec 19913.9143.63B11.16B
FY199031 Dec 19903.2233.19B10.30B
FY198931 Dec 19893.0127.66B9.19B
FY198831 Dec 19882.6322.51B8.56B
FY198731 Dec 19872.8021.17B7.56B

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Bristol-Myers Squibb's P/S ratio

Source: Financial Modeling PrepVerified against SEC filings